Myths vs facts: Pharmakogenetik Medicheck and fatigue

Pharmacogenetics examines how genetic variants affect drug response and tolerability. A 'Pharmakogenetik Medicheck' may reveal altered enzyme activities (e.g., CYP2D6, CYP2C19) that slow or accelerate drug metabolism. However, fatigue as a side effect is usually multifactorial: it can stem from the underlying condition, lifestyle, drug interactions, or the medication itself. Current studies indicate that single gene variants (e.g., in the serotonin transporter SLC6A4 or the circadian gene ZNF185) explain only a small fraction of fatigue risk. The evidence is mostly mechanistic or from small association studies. A direct causal link between a genetic test and the occurrence of fatigue is not well established. The value of such checks lies more in dose adjustment and avoiding over‑/underdosing, not in predicting fatigue. Consumers should treat results as complementary information, not as a sole basis for therapy decisions. A physician consultation remains essential.